期刊文献+

35-40岁多囊卵巢综合征患者卵巢功能研究 被引量:5

Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome
下载PDF
导出
摘要 目的研究生育能力开始下降的多囊卵巢综合征(PCOS)患者体内促性腺激素、卵巢类固醇和PCOS卵巢储备情况,并探讨其卵巢功能。方法 40例35-40岁PCOS患者和35名健康妇女纳入本次研究。详细了解患者病史、并对患者进行常规体格检查、阴式超声检测和醋酸亮丙瑞林测试。此外,还检测了促性腺激素、类固醇激素、性激素结合球蛋白、抑制素B和AMH的含量。结果两组LH的低值和峰值水平相近。FSH低值和峰值水平分别显著高于正常对照组。PCOS患者组的雄激素、雌二醇峰值、卵巢体积、窦状卵泡数目和AMH水平均显著高于正常对照组。结论晚育PCOS患者体内的促性腺激素分泌显著区别于对照组女性,且可能与年轻的PCOS妇女有显著区别。女性高卵巢储备的新特征如正常LH和低FSH水平可能带给她们不同的生殖情况。 【Objective】To assess gonadotrophin secretion, ovarian steroid production and ovarian reserve in PCOS women during the onset of reproductive decline, in order to characterize their ovarian function at this age.【Methods】Forty PCOS patients and 35 healthy women(35-40 years of age) were included. Clinical history, anthropometry,transvaginal ultrasound and a leuprolide acetate test(10 mg/kg s.c.) were performed. Gonadotrophins, steroid hormones, SHBG, inhibin B and AMH were determined. 【Results】Basal and peak LH levels were similar in both groups. Basal and peak FSH levels were significantly higher in the control group. Androgens, peak oestradiol, ovarian volume, antral follicle count and AMH levels were significantly higher in PCOS patients. 【Conclusions】These observations suggest that during late reproductive age, gonadotrophin secretion in women with PCOS is clearly different from that observed in control women and may also differ from that of younger PCOS patients. New features like normal LH and lower FSH levels associated with a higher ovarian reserve may give a different reproductive profile to these women.
作者 钟雪辉
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第18期75-79,共5页 China Journal of Modern Medicine
关键词 多囊卵巢综合征 卵巢功能 卵泡刺激素 黄体素 polycystic ovary syndrome ovarian function follicle-stimulating hormone luteinizing hormone
  • 相关文献

参考文献11

  • 1王丽琼,施晓波,丁依玲,朱付凡,符书馨.多囊卵巢综合征月经周期与内分泌代谢失调[J].中国现代医学杂志,2012,22(29):76-79. 被引量:10
  • 2SMITH JW, TAYLOR JS. Polycystic ovary syndrome[J]. Nursing for Women's Health, 2011, 15(5): 402-411.
  • 3郭慧,龚斐,罗克丽,朱文兵,卢光琇.两种雌孕激素替代法内膜准备对多囊卵巢综合征冷冻胚胎移植临床效果的比较[J].中国现代医学杂志,2013,23(2):74-77. 被引量:17
  • 4GOODARZI MO, DUMESIC DA, CHAZENBALK G, et al. Poly- cystic ovary syndrome: etiology, pathogenesis and diagnosis [J]. Nature Reviews Endocrinology, 2011, 7(4): 219-231.
  • 5WISER A, SHEHATA F, HOLZER H, et al. Effect of high LH/FSH ratio on women with polycystic ovary syndrome under- going in vitro maturation treatment [J]. The Journal of Reproduc- tive Medicine, 2012, 58(5-6): 219-223.
  • 6CARMINA E, LOBO RA. Polycystic ovary syndrome (PCOS): ar- guably the most common endoerinopathy is associated with sig- nificant morbidity in women[J]. Journal of Clinical Endocrinology & Metabolism, 1999, 84(6): 1897-1899.
  • 7JAKUBOWICZ D, BARNEA M, WAINSTEIN J, et al. Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome[J]. Clinical Sci- ence, 2013, 125(9): 423-432.
  • 8饶龙泉.腹腔镜卵巢打孔术对多囊卵巢综合征患者抗苗勒激素水平的影响[J].中国内镜杂志,2013,19(6):589-592. 被引量:9
  • 9PERALES-PUCHALT A, LEGRO RS. Ovulation induction in women with polycystic ovary syndrome [J]. Steroids, 2013, 78(8): 767-772.
  • 10TEEDE H, NG S, HEDGER M, et al. Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers[J]. Metabolism, 2013, 62(10): 1394-1400.

二级参考文献39

  • 1陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗[J].中华妇产科杂志,2007,42(5):289-290. 被引量:69
  • 2陈子江.多囊卵巢综合征相关病因及临床研究——来自山东大学生殖医学中心的报告[J].生殖医学杂志,2007,16(4):232-235. 被引量:45
  • 3EISENHARDT S, SCHWARZMANN N, HENSCHEL V, et al. Early effects of metformin in women with polycystic ovary syndrome:a prospective randomized, doubleblind, placebo-controlled [J]. J Clin Endocrinol Metab, 2006, 91: 946-952.
  • 4AZZIZ R. Controversy in clinical endocrinology:diagnosis of polycystic orarian syndrome: the rotterdam criteria are premature[J]. J Clin Endocrinol Metab, 2006, 91: 781-785.
  • 5CHEN YX, YANG DZ, LIN L, et al. The role of ovarian volume as a diagnostic criterion for chinese adolescents with polycystic ovary syndrome[J]. J Pediatr Adolesc Gynecol, 2008, 21: 347-350.
  • 6BERNEIS K, RIZZO M, HERBERGER M, et al. Atherogenic forms of dyslipdaemia in women with polycystic ovary syndrome [J]. Int J Clin Pract, 2009, 63: 56-62.
  • 7BERNEIS K, RIZZO M, LAZZARINI V, et al. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2007, 92: 186-189.
  • 8CUSSONS AJ, STUCKEY BG, WATTS GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives[J]. Atherosclerosis, 2006, 185: 227-239.
  • 9CARMINA E, BUCCHIERI S, ESPOSITO A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance[J]. J Clin Endocrinol Metab, 2007, 92: 2500-2505.
  • 10STROWITZKI T, CAPP E, CORLETA HE. The degree of cycle irrgularity correlates with the grade of endocrine and metabolic disorders in PCOS patiens[J]. Eur J obstet & Gynecol, 2010, 149: 178-181.

共引文献33

同被引文献82

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部